Novartis results in line with requirements of the US Securities and Exchange Commission (SEC). 2022 Form 20-F/A 2022 (PDF 3.8 MB) 2021 English (PDF 3.4 MB) View Amendment No. 1 to Novartis Form 20-F for 2021 (dated April 26, 2022 | PDF 0.2 MB) 2020 English (PDF 3.4 MB) 2019 English (PDF 4.1 MB) 2018 English (PDF 3.9 MB) 2017 English (PDF 4.2 MB) 2016 English (PDF 2.9 MB) 2015 English (PDF 9.1 MB) 2014 English (PDF 2.5 MB) 2013 English (PDF 9.6 MB) 2012 English (PDF 2.0 MB) 2011 English (PDF 2.0 MB) 2010 English (PDF 1.6 MB) 2009 English (PDF 1.4 MB) 2008 English (PDF 1.1 MB) 2007 English (PDF 1.4 MB) 2006 English (PDF 1.8 MB) 2005 English (PDF 1.4 MB) 2004 English (PDF 2.0 MB) PrintPDF